New global initiative launched to improve mpox vaccine access

On August 27, 2026, a significant global effort was launched to establish a permanent mpox vaccine stockpile.

Managed by the International Coordinating Group (ICG)—which includes organizations like the WHO and UNICEF—the stockpile represents a shift from reactive emergency measures to a sustainable, long-term health strategy.

This move directly addresses the inequities seen during the 2022 outbreak, when lower-income nations struggled to compete with wealthier countries for limited supplies.

By providing vaccines free of charge to eligible nations based on public health need, the initiative ensures that access is no longer determined by a country's financial status.

Furthermore, by creating a predictable demand-based mechanism, it provides vaccine manufacturers with clear signals for future production.

This landmark initiative marks a turning point in global health preparedness, ensuring that the world is better equipped to manage future outbreaks through cooperation rather than competition.